A Clinician’s Perspective: Gene Therapy for X-Linked Myotubular Myopathy
Time: 8:45 am
day: Day One
Details:
- -X-Linked Myotubular Myopathy (XLMTM): Burden of disease
- Gene therapy and efficacy outcomes
- Safety profile and liver toxicity
